tiprankstipranks
Evolutionary Genomics Inc (FNAM)
OTHER OTC:FNAM
US Market

Evolutionary Genomics (FNAM) Stock Price & Analysis

1 Followers

FNAM Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.45 - $0.80
Previous Close$0.45
Volume55.00
Average Volume (3M)N/A
Market Cap
$2.99M
Enterprise Value$6.16M
Total Cash (Recent Filing)$577.07K
Total Debt (Recent Filing)$3.74M
Price to Earnings (P/E)-1.3
Beta-0.33
May 15, 2018
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)-0.35
Shares Outstanding6,655,232
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.29
R-Squared0.00111
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-6.74
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

32.26%0.00%0.00%67.74%
32.26%
Insiders
0.00%
Mutual Funds
0.00% Other Institutional Investors
67.74% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

FNAM FAQ

What was Evolutionary Genomics Inc’s price range in the past 12 months?
Evolutionary Genomics Inc lowest stock price was $0.45 and its highest was $0.80 in the past 12 months.
    What is Evolutionary Genomics Inc’s market cap?
    Currently, no data Available
    When is Evolutionary Genomics Inc’s upcoming earnings report date?
    Evolutionary Genomics Inc’s upcoming earnings report date is May 15, 2018 which is 2144 days ago.
      How were Evolutionary Genomics Inc’s earnings last quarter?
      Currently, no data Available
      Is Evolutionary Genomics Inc overvalued?
      According to Wall Street analysts Evolutionary Genomics Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Evolutionary Genomics Inc pay dividends?
        Evolutionary Genomics Inc does not currently pay dividends.
        What is Evolutionary Genomics Inc’s EPS estimate?
        Evolutionary Genomics Inc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Evolutionary Genomics Inc have?
        Evolutionary Genomics Inc has 6,655,232 shares outstanding.
          What happened to Evolutionary Genomics Inc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Evolutionary Genomics Inc?
          Currently, no hedge funds are holding shares in FNAM
          ---

          Evolutionary Genomics Stock Smart Score

          Company Description

          Evolutionary Genomics Inc

          Evolutionary Genomics, Inc. engages in developing and marketing an interactive information and advertising service. Its gene portfolio includes soybean pest and disease resistance, tomato sweetness and salt tolerance, cotton project, rice yield, wheat stern rust resistance, and cassava disease resistance. The company was founded by Walter Messier and Virginia Orndorff in November 1990 and is headquartered in Castle Rock, CO.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Genetic Technologies
          Evogene
          Crispr Therapeutics AG
          Editas Medicine
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis